|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Matsuo K, Ramzan AA, Gualtieri MR,
Mhawech-Fauceglia P, Machida H, Moeini A, Dancz CE, Ueda Y and
Roman LD: Prediction of concurrent endometrial carcinoma in women
with endometrial hyperplasia. Gynecol Oncol. 139:261–267. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nagano T and Fraser P: No-nonsense
functions for long noncoding RNAs. Cell. 145:178–181. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rafiee A, Riazi-Rad F, Havaskary M and
Nuri F: Long noncoding RNAs: Regulation, function and cancer.
Biotechnol Genet Eng Rev. 34:153–180. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Quinn JJ and Chang HY: Unique features of
long non-coding RNA biogenesis and function. Nat Rev Genet.
17:47–62. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ferlita A, Battaglia R, Andronico F,
Caruso S, Cianci A, Purrello M and Pietro CD: Non-coding RNAs in
endometrial physiopathology. Int J Mol Sci. 19:21202018. View Article : Google Scholar
|
|
7
|
Dong P, Xiong Y, Yue J, Hanley SJB,
Kobayashi N, Todo Y and Watari H: Exploring lncRNA-mediated
regulatory networks in endometrial cancer cells and the tumor
microenvironment: Advances and challenges. Cancers (Basel).
11:2342019. View Article : Google Scholar
|
|
8
|
Friedman JM and Jones PA: MicroRNAs:
Critical mediators of differentiation, development and disease.
Swiss Med Wkly. 139:466–472. 2009.PubMed/NCBI
|
|
9
|
Iorio MV, Visone R, Di Leva G, Donati V,
Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, et
al: MicroRNA signatures in human ovarian cancer. Cancer Res.
67:8699–8707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yonemori K, Kurahara H, Maemura K and
Natsugoe S: MicroRNA in pancreatic cancer. J Hum Genet. 62:33–40.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Stope MB, Koensgen D, Weimer J, Paditz M,
Burchardt M, Bauerschlag D and Mustea A: The future therapy of
endometrial cancer: microRNA's functionality, capability, and
putative clinical application. Arch Gynecol Obstet. 294:889–895.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dong P, Xiong Y, Yue J, Xu D, Ihira K,
Konno Y, Kobayashi N, Todo Y and Watari H: Long noncoding RNA NEAT1
drives aggressive endometrial cancer progression via
miR-361-regulated networks involving STAT3 and tumor
microenvironment-related genes. J Exp Clin Cancer Res. 38:2952019.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lv Y, Chen S, Wu J, Lin R, Zhou L, Chen G,
Chen H and Ke Y: Upregulation of long non-coding RNA OGFRP1
facilitates endometrial cancer by regulating miR-124-3p/SIRT1 axis
and by activating PI3K/AKT/GSK-3β pathway. Artif Cells Nanomed
Biotechnol. 47:2083–2090. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tian Y, Chen YY and Han AL: MiR-1271
inhibits cell proliferation and metastasis by targeting LDHA in
endometrial cancer. Eur Rev Med Pharmacol Sci. 23:5648–5656.
2019.PubMed/NCBI
|
|
15
|
He Z, Xu H, Meng Y and Kuang Y: miR-944
acts as a prognostic marker and promotes the tumor progression in
endometrial cancer. Biomed Pharmacother. 88:902–910. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jin C and Liang R: miR-205 promotes
epithelial-mesenchymal transition by targeting AKT signaling in
endometrial cancer cells. J Obstet Gynaecol Res. 41:1653–1660.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li BL, Lu C, Lu W, Yang TT, Qu J, Hong X
and Wan XP: miR-130b is an EMT-related microRNA that targets DICER1
for aggression in endometrial cancer. Med Oncol. 30:4842013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin C, Zhang S, Wang Y, Wang Y, Nice E,
Guo C, Zhang E, Yu L, Li M, Liu C, et al: Functional role of a
novel long noncoding RNA TTN-AS1 in esophageal squamous cell
carcinoma progression and metastasis. Clin Cancer Res. 24:486–498.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cui Z, Luo Z, Lin Z, Shi L, Hong Y and Yan
C: Long non-coding RNA TTN-AS1 facilitates tumorigenesis of
papillary thyroid cancer through modulating the miR-153-3p/ZNRF2
axis. J Gene Med. 21:e30832019. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Luo JF, Xu J and Zheng JZ: Long non-coding
RNA TTN-AS1 promotes cell proliferation and inhibits cell apoptosis
in prostatic cancer by sponging miR-193a-5p. Eur Rev Med Pharmacol
Sci. 23:7816–7825. 2019.PubMed/NCBI
|
|
21
|
Wang H, Meng F, Zhang B, Jiang P, Hu M, Yu
X and Cao H: Long non-coding RNA TTN-AS1 aggravates carcinogenesis
through Wnt/β-catenin signaling pathway by sponging miR-1271 in
hepatocellular carcinoma. Minerva Med. Jul 9–2019.(Epub ahead of
print).
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li JH, Liu S, Zhou H, Qu LH and Yang JH:
starBase v2.0: Decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA
interaction networks from large-scale CLIP-Seq data. Nucleic Acids
Res. 42((Database issue)): D92–D97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang L, Wang DL and Yu P: LncRNA H19
regulates the expression of its target gene HOXA10 in endometrial
carcinoma through competing with miR-612. Eur Rev Med Pharmacol
Sci. 22:4820–4827. 2018.PubMed/NCBI
|
|
25
|
Wang L, Zhao S and Mingxin YU: LncRNA
NR2F1-AS1 is involved in the progression of endometrial cancer by
sponging miR-363 to target SOX4. Pharmazie. 74:295–300.
2019.PubMed/NCBI
|
|
26
|
Yu J, Jiang L, Gao Y, Sun Q, Liu B, Hu Y
and Han X: LncRNA CCAT1 negatively regulates miR-181a-5p to promote
endometrial carcinoma cell proliferation and migration. Exp Ther
Med. 17:4259–4266. 2019.PubMed/NCBI
|
|
27
|
Huang Y, Ni R, Wang J and Liu Y: Knockdown
of lncRNA DLX6-AS1 inhibits cell proliferation, migration and
invasion while promotes apoptosis by downregulating PRR11
expression and upregulating miR-144 in non-small cell lung cancer.
Biomed Pharmacother. 109:1851–1859. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Luo J and Liu Z: Long non-coding RNA
TTN-AS1 promotes the progression of lung adenocarcinoma by
regulating PTEN/PI3K/AKT signaling pathway. Biochem Biophys Res
Commun. 514:140–147. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dong MM, Peng SJ, Yuan YN and Luo HP:
LncRNA TTN-AS1 contributes to gastric cancer progression by acting
as a competing endogenous RNA of miR-376b-3p. Neoplasma.
66:564–575. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen P, Wang R, Yue Q and Hao M: Long
non-coding RNA TTN-AS1 promotes cell growth and metastasis in
cervical cancer via miR-573/E2F3. Biochem Biophys Res Commun.
503:2956–2962. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chan JJ and Tay Y: Noncoding RNA:RNA
regulatory networks in cancer. Int J Mol Sci. 19:13102018.
View Article : Google Scholar
|
|
32
|
Fan XR, Zhang ZY, Wang RH, Li Y and Mao
QZ: MiR-376a functions as tumor suppressor by targeting SGK3 in
renal cell carcinoma. Eur Rev Med Pharmacol Sci. 23:3726–3732.
2019.PubMed/NCBI
|
|
33
|
Yang L, Wei QM, Zhang XW, Sheng Q and Yan
XT: MiR-376a promotion of proliferation and metastases in ovarian
cancer: Potential role as a biomarker. Life Sci. 173:62–67. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xu Q, Cheng L, Chen J, Lu W and Wang P:
miR-376a inhibits the proliferation and invasion of osteosarcoma by
targeting FBXO11. Hum Cell. 32:390–396. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Formosa A, Markert EK, Lena AM, Italiano
D, Finazzi-Agro' E, Levine AJ, Bernardini S, Garabadgiu AV, Melino
G and Candi E: MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c,
miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p,
mapped to the 14q32.31 locus, regulate proliferation, apoptosis,
migration and invasion in metastatic prostate cancer cells.
Oncogene. 33:5173–5182. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Herr I, Sähr H, Zhao Z, Yin L, Omlor G,
Lehner B and Fellenberg J: MiR-127 and miR-376a act as tumor
suppressors by in vivo targeting of COA1 and PDIA6 in giant cell
tumor of bone. Cancer Lett. 409:49–55. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zehavi L, Avraham R, Barzilai A, Bar-Ilan
D, Navon R, Sidi Y, Avni D and Leibowitz-Amit R: Silencing of a
large microRNA cluster on human chromosome 14q32 in melanoma:
Biological effects of mir-376a and mir-376c on insulin growth
factor 1 receptor. Mol Cancer. 11:442012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhang L, Chen Y, Li C, Liu J, Ren H, Li L,
Zheng X, Wang H and Han Z: RNA binding protein PUM2 promotes the
stemness of breast cancer cells via competitively binding to
neuropilin-1 (NRP-1) mRNA with miR-376a. Biomed Pharmacother.
114:1087722019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang L, Chen Y, Wang H, Zheng X, Li C and
Han Z: miR-376a inhibits breast cancer cell progression by
targeting neuropilin-1 NR. Onco Targets Ther. 11:5293–5302. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wang Y, Cong W, Wu G, Ju X, Li Z, Duan X,
Wang X and Gao H: MiR-376a suppresses the proliferation and
invasion of non-small-cell lung cancer by targeting c-Myc. Cell
Biol Int. 42:25–33. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zheng Y, Chen H, Yin M, Ye X, Chen G, Zhou
X, Yin L, Zhang C and Ding B: MiR-376a and histone deacetylation 9
form a regulatory circuitry in hepatocellular carcinoma. Cell
Physiol Biochem. 35:729–739. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang Y, Sun W, Yang J, Yang L, Li C, Liu
H, Liu X and Jiao B: PUM2 promotes glioblastoma cell proliferation
and migration via repressing BTG1 expression. Cell Struct Funct.
44:29–39. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Galgano A, Forrer M, Jaskiewicz L, Kanitz
A, Zavolan M and Gerber AP: Comparative analysis of mRNA targets
for human PUF-family proteins suggests extensive interaction with
the miRNA regulatory system. PLoS One. 3:e31642008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang M, Chen D, Xia J, Han W, Cui X,
Neuenkirchen N, Hermes G, Sestan N and Lin H: Post-transcriptional
regulation of mouse neurogenesis by Pumilio proteins. Genes Dev.
31:1354–1369. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hu R, Zhu X, Chen C, Xu R, Li Y and Xu W:
RNA-binding protein PUM2 suppresses osteosarcoma progression via
partly and competitively binding to STARD13 3′UTR with miRNAs. Cell
Prolif. 51:e125082018. View Article : Google Scholar : PubMed/NCBI
|
